Efficacy and Safety Assessment of ZOlpidem (Stilnox CR) Administered on as Needed Basis in Patients With Chronic insomNIA.

Trial Profile

Efficacy and Safety Assessment of ZOlpidem (Stilnox CR) Administered on as Needed Basis in Patients With Chronic insomNIA.

Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Oct 2010

At a glance

  • Drugs Zolpidem (Primary)
  • Indications Insomnia
  • Focus Therapeutic Use
  • Sponsors Sanofi
  • Most Recent Events

    • 04 Oct 2010 Actual end date (Jul 2010) added as reported by ClinicalTrials.gov.
    • 04 Oct 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 14 Jun 2010 Planned end date changed from 1 Jun 2010 to 1 Aug 2010 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top